BLOSSOMHILL THERAPEUTICS Trademark

Trademark Overview

On Monday, June 29, 2020, a trademark application was filed for BLOSSOMHILL THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the BLOSSOMHILL THERAPEUTICS trademark a serial number of 90026952. The federal status of this trademark filing is REGISTERED as of Tuesday, October 5, 2021. This trademark is owned by BlossomHill Therapeutics, Inc.. The BLOSSOMHILL THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the pharmaceutical and biotechnology fields
blossomhill therapeutics

General Information

Serial Number90026952
Word MarkBLOSSOMHILL THERAPEUTICS
Filing DateMonday, June 29, 2020
Status700 - REGISTERED
Status DateTuesday, October 5, 2021
Registration Number6512542
Registration DateTuesday, October 5, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 1, 2021

Trademark Statements

Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesResearch and development in the pharmaceutical and biotechnology fields

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, July 28, 2020
Primary Code042
First Use Anywhere DateTuesday, June 23, 2020
First Use In Commerce DateTuesday, June 23, 2020

Trademark Owner History

Party NameBlossomHill Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameBlossomHill Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameBlossomHill Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Tuesday, October 5, 2021REGISTERED-PRINCIPAL REGISTER
Wednesday, September 1, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, August 31, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, August 19, 2021STATEMENT OF USE PROCESSING COMPLETE
Wednesday, August 11, 2021USE AMENDMENT FILED
Thursday, August 19, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, August 11, 2021TEAS STATEMENT OF USE RECEIVED
Tuesday, July 27, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, July 22, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, July 22, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 22, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 1, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 1, 2021PUBLISHED FOR OPPOSITION
Wednesday, May 12, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, April 29, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 28, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 28, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 28, 2021ASSIGNED TO LIE
Thursday, January 14, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 13, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, January 13, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 13, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 13, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 13, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, September 30, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 30, 2020NON-FINAL ACTION E-MAILED
Wednesday, September 30, 2020NON-FINAL ACTION WRITTEN
Wednesday, September 30, 2020ASSIGNED TO EXAMINER
Tuesday, July 28, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, July 2, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

therapeutics blossomhill fields biotechnology pharmaceutical development research